Document Detail


What's new in psoriasis? Analysis of the clinical significance of new guidelines and systematic reviews on psoriasis published in 2008 and 2009.
MedLine Citation:
PMID:  20545953     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This review summarizes the clinical importance of 18 systematic reviews and guidelines on psoriasis published or indexed between November 2008 and October 2009. The topics covered include guidance on the use of topical, systemic and biological therapies for the treatment of psoriasis; comorbidities associated with psoriasis; and complementary therapies for psoriasis. A similar and more detailed review to this appeared in the 2009 Annual Evidence Update on Psoriasis from NHS Evidence - Skin Disorders in November 2009.
Authors:
R B Warren; B C Brown; D J C Grindlay; C E M Griffiths
Related Documents :
2477993 - Macroamylasemia: a simple stepwise approach to diagnosis.
25443283 - Three root canals in the mesiobuccal root of maxillary molars: case reports and literat...
15210083 - The unrecognised french bse epidemic.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinical and experimental dermatology     Volume:  35     ISSN:  1365-2230     ISO Abbreviation:  Clin. Exp. Dermatol.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-13     Completed Date:  2010-10-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7606847     Medline TA:  Clin Exp Dermatol     Country:  England    
Other Details:
Languages:  eng     Pagination:  688-91; quiz 692     Citation Subset:  IM    
Copyright Information:
© 2010 The Author(s). Journal compilation © 2010 British Association of Dermatologists.
Affiliation:
Dermatological Sciences, Salford Royal NHS Foundation Trust, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. richard.warren@manchester.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Dermatologic Agents / therapeutic use
Humans
Immunologic Factors / therapeutic use
Practice Guidelines as Topic*
Psoriasis / drug therapy*
Review Literature as Topic*
Chemical
Reg. No./Substance:
0/Dermatologic Agents; 0/Immunologic Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  T-cell clone associated with efalizumab therapy.
Next Document:  Homocysteine status and cardiovascular risk factors in patients with psoriasis: a case-control study...